Hospital Wastewater Segregation: STP Guide

Hospital Wastewater Segregation: Which Streams Should Not Enter the STP?

A hospital produces more than ordinary sewage. Toilets and showers generate sanitary wastewater, while laboratories, pharmacies and specialist treatment departments may generate liquids with different chemical, pharmaceutical or radiological risks.

Hospital wastewater segregation means identifying these streams where they originate and assigning each an appropriate collection and treatment route. For UAE healthcare facilities, this assessment should happen before drainage connections are approved or a sewage treatment plant (STP) is selected.

Start with the Drainage Source

The DHA sanitary drainage design guidance distinguishes wastewater, soil-water, stormwater, chemical and radiation drainage. It recognises dedicated laboratory drainage and specialist radiation drainage, with combinations possible where the approved design allows.

The practical lesson is to classify the discharge before connecting it. A handwashing basin and a sink used for laboratory reagents may look similar, but their wastewater cannot automatically be assigned the same route.

Create a department-by-department inventory showing each fixture, its intended use, discharge characteristics and destination. Include temporary equipment and later alterations, which may not appear on the original drawings.

Which Hospital Streams Need Separate Assessment?

The table below is an assessment guide, not permission to discharge. Final arrangements depend on the facility’s activities, approved waste procedures and applicable authority requirements.

Laboratory Waste: Neutral pH Is Not the Whole Answer

A laboratory discharge can have acceptable pH and still contain unsuitable chemicals. Neutralisation changes acidity or alkalinity; it does not automatically remove solvents, metals or hazardous organic compounds.

Review the chemical inventory, safety data sheets, equipment discharge instructions and waste volumes. Identify which liquids require container collection and which may use an approved chemical drainage system. Keep incompatible wastes separate.

The WHO healthcare-waste factsheet identifies laboratory solvents, reagents, disinfectants and heavy metals among chemical-waste concerns. A general-purpose STP specification does not establish that these materials are acceptable influent.

Discarded Medicines Differ from Patient Excretion

Unused medicines and cytotoxic waste should follow documented collection and disposal procedures. Do not use a sink or toilet as the default disposal point simply because the product is liquid.

WHO’s 2025 pharmaceutical-waste guidance distinguishes waste categories and management options. Its context-specific options do not provide blanket approval for disposal into a UAE hospital drain.

Patient excretion is a different pathway. WHO explains that medicine residues can enter sewage after patient use as well as through uncontrolled disposal. Segregating discarded products therefore reduces avoidable inputs but cannot eliminate every pharmaceutical residue from sanitary wastewater.

Special precautions for patients receiving particular therapies must follow the hospital’s clinical and waste-management protocols.

Radioactive Liquids Need Authorised Arrangements

Radioactive waste is not ordinary chemical effluent. Refer relevant nuclear-medicine and laboratory discharges to the radiation-protection officer and the facility’s authorised procedures.

FANR radioactive-waste guidance addresses controlled discharge and the need to consider chemical hazards alongside radioactivity. Any holding, monitoring or release arrangement must suit the radionuclide, activity and applicable authorisation. A generic retention period or ordinary STP cannot be assumed sufficient.

Why MBR Does Not Replace Segregation

Membrane bioreactor technology combines biological treatment with membrane separation. It can provide effective solids removal and support treatment of suitable sanitary wastewater, but membrane filtration alone does not remove every dissolved contaminant.

The US EPA MBR factsheet distinguishes solids separation from treatment of dissolved constituents. Consequently, clear effluent is not evidence that all pharmaceuticals, chemicals or radiological hazards have been removed.

Define accepted influent and the required outlet quality before selecting biological treatment, disinfection or additional polishing. A low BOD or TSS result alone cannot establish suitability for every reuse application.

A Practical Hospital Wastewater Segregation Review

Bring facilities engineering, infection prevention, laboratory management, pharmacy and radiation protection together. Review:

• Actual drain connections against current drawings.
• Departmental chemicals and specialist waste procedures.
• Normal flows, batch releases and cleaning schedules.
• Collection points, labels and staff instructions.
• Sampling locations and treatment-system acceptance criteria.
• Changes introduced by new equipment or departments.

Record unresolved discharges for specialist review instead of assuming they are ordinary sewage. Assign responsibility for keeping the inventory and drawings current after modifications.

Plan the STP around Approved Inputs

Provide Almasa with the drainage inventory, accepted wastewater sources, flow data, laboratory results and required discharge or reuse objective. These inputs help define the treatment scope and identify information needed before a proposal.

See Almasa’s hospital wastewater treatment solutions and sewage treatment plant systems for related engineering services.

Contact Almasa Environmental Solutions to discuss treatment of the facility’s approved wastewater streams or an existing STP assessment.